Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:209-213
doi: 10.1161/hy0202.103442
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iglarz, M.
Right arrow Articles by Henrion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iglarz, M.
Right arrow Articles by Henrion, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Genetics of cardiovascular disease
Right arrow Other Vascular biology

(Hypertension. 2002;39:209.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro

Marc Iglarz; Joëlle Benessiano; Ivan Philip; Sandrine Vuillaumier-Barrot; Sigismond Lasocki; Ulrich Hvass; Geneviève Durand; Jean-Marie Desmonts; Bernard I. Lévy; Daniel Henrion

From the Institut National de la Santé et de la Recherche Médicale (INSERM) U 541,IFR Circulation-Paris VII, Université Paris VII (M.I., D.H.), Paris, France; Service de Physiologie, Université Paris VII, AP-HP-Hôpital Lariboisière (B.I.L.), Paris, France; and Laboratoire de Biochimie (J.B., S.V-B., G.D.), Service d’Anesthésie-Réanimation (I.P., J-M.D.), and Service de Chirurgie Cardiaque (S.L., U.H.), AP-HP-Hôpital Xavier Bichat, Paris, France.

Correspondence to D. Henrion, PhD, INSERM U 541, 41 Bd de la Chapelle, 75475 Paris, cedex 10, France. E-mail daniel.henrion{at}inserm.lrb.ap-hop-paris.fr

A gene polymorphism of preproendothelin-1 (a G-to-T transversion that predicts a Lys/Asn change at codon 198) associated with an increased risk of hypertension has been recently described in patients carrying the T allele. No study has yet determined the impact of this polymorphism on vascular reactivity, although a functional role for endothelin-1 in the pathophysiology of hypertension has been clarified. At subthreshold concentrations, endothelin-1 and angiotensin II induce a potentiation of {alpha}-adrenergic–dependent vascular tone caused by an increased sensitivity of the contractile apparatus to calcium. We investigated phenylephrine-induced tone and its amplification by endothelin-1 and angiotensin II in human mammary artery rings in vitro. Contractions to phenylephrine (0.1 to 100 µmol) and endothelin-1 (0.1 to 300 nmol) were not significantly different in rings from GT/TT (n=27) and GG (n=21) patients. A subthreshold concentration of endothelin-1 (10 pmol) potentiated a phenylephrine-induced contraction (eg, 44±12% increase in tone with phenylephrine 1 µmol/L, P<0.001) that was significantly higher in the GT/TT group than in the GG group (eg, 44±12% versus 82±11%, P<0.01). A similar effect on response to phenylephrine was observed with a subthreshold concentration of angiotensin II. We also found a higher response to calcium in arteries from GT/TT patients. Endothelium-dependent or -independent relaxations were unaffected by the genotype. These data suggest that the preproendothelin-1 gene polymorphism is associated with a higher potentiating effect of endothelin-1 and angiotensin II, probably in relation with higher calcium sensitivity. These changes in vascular reactivity might help to understand the relations between this polymorphism and cardiovascular disorders.


Key Words: blood vessels • polymorphism • endothelin • phenylephrine • angiotensin II




This article has been cited by other articles:


Home page
In VivoHome page
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
In Vivo, September 1, 2009; 23(5): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kirshbom, W. T. Mahle, R. W. Joyner, T. Leong, M. Wilson, B. E. Kogon, K. R. Kanter, and M. M. Bouzyk
The endothelin-1 G5665T polymorphism impacts transplant-free survival for single ventricle patients
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Rankinen, T. Church, T. Rice, N. Markward, A. S. Leon, D. C. Rao, J. S. Skinner, S. N. Blair, and C. Bouchard
Effect of Endothelin 1 Genotype on Blood Pressure Is Dependent on Physical Activity or Fitness Levels
Hypertension, December 1, 2007; 50(6): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder
Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity
Hypertension, October 1, 2003; 42(4): 494 - 499.
[Abstract] [Full Text] [PDF]